Literature DB >> 16671023

Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers.

Nobuyuki Harada1, Yutsuki Nakajima, Kazue Higuchi, Yukie Sekiya, Jim Rothel, Toru Mori.   

Abstract

OBJECTIVE: To examine the hypothesis that results of the QuantiFERON-TB Gold assay (QFT-G), a whole-blood test for detection of tuberculosis infection, are more significantly related to known risk factors for tuberculosis infection in healthcare workers (HCWs) who have received bacille Calmette-Guerin vaccine than are results of the Mantoux tuberculin skin test (TST).
DESIGN: All HCWs (approximately 510) from a 370-bed general hospital in Tokyo where patients with and patients without tuberculosis are treated were invited to participate in the study. All study participants completed a questionnaire about their Mycobacterium tuberculosis infection risk factors as HCWs at the general hospital. They were then tested for LTBI by means of the QFT-G, followed by the TST. Statistical analyses were performed to compare results of each test with M. tuberculosis infection risk factors (age, length of employment in the healthcare industry, history of working with tuberculosis-positive patients in a tuberculosis ward or in the outpatient department of the hospital's tuberculosis clinic for more than 1 year, chest radiograph evidence of healed tuberculosis, history of performing bronchoscope procedures, and job classification), and for TST-positive HCWs, to compare the QFT-G result with the TST induration diameter.
RESULTS: A total of 332 HCWs (95% of whom had been vaccinated with BCG) participated in the study, and 33 had positive QFT-G results, suggesting a prevalence of LTBI of 9.9%. Of 304 HCWs who underwent TST, 283 (93.1%) had an induration diameter of 10 mm or more. Multiple logistic regression analysis revealed that positive QFT-G results were significantly associated with age and with a history of working in a tuberculosis ward or an outpatient department of a tuberculosis clinic. TST results were not correlated with any of the tuberculosis infection risk factors we evaluated.
CONCLUSIONS: Positive QFT-G results were closely associated with the presence of risk factors for LTBI in a hospital setting, suggesting that the QFT-G can detect LTBI in a population composed predominantly of BCG vaccinees. Because most HCWs worldwide have been vaccinated with BCG, the QFT-G offers a significant improvement over the TST in tuberculosis screening programs and minimizes unwarranted use of tuberculosis prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16671023     DOI: 10.1086/504358

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  47 in total

1.  Latent tuberculosis infection screening for laboratory personnel using interferon-γ release assay and tuberculin skin test in Korea: an intermediate incidence setting.

Authors:  Hee-Won Moon; Hanah Kim; Mina Hur; Yeo-Min Yun; Anna Lee
Journal:  J Clin Lab Anal       Date:  2011-11       Impact factor: 2.352

2.  Utilization of the QuantiFERON-TB Gold test in a two-step process with the tuberculin skin test to evaluate health care workers for latent tuberculosis.

Authors:  Baha Abdalhamid; Steven H Hinrichs; Jodi L Garrett; Jean M O'Neill; Kristine M Hansen-Cain; Amy A Armbrust; Peter C Iwen
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

3.  The QuantiFERON-TB-GOLD assay for tuberculosis screening in healthcare workers: a cost-comparison analysis.

Authors:  Benjamin D Fox; Mordechai R Kramer; Zohar Mor; Rachel Preiss; Victoria Rusanov; Leonardo Fuks; Nir Peled; Ilanit Haim; Meir Raz; David Shitrit
Journal:  Lung       Date:  2009-10-15       Impact factor: 2.584

4.  Preventing tuberculosis in children receiving anti-TNF treatment.

Authors:  Nuray Aktay Ayaz; Erkan Demirkaya; Yelda Bilginer; Uğur Ozçelik; Nazan Cobanoğlu; Nural Kiper; Nesrin Besbas; Aysin Bakkaloğlu; Seza Ozen
Journal:  Clin Rheumatol       Date:  2010-04       Impact factor: 2.980

5.  Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study.

Authors:  Anja Schablon; Melanie Harling; Roland Diel; Albert Nienhaus
Journal:  BMC Infect Dis       Date:  2010-04-30       Impact factor: 3.090

6.  Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers.

Authors:  Felix C Ringshausen; Albert Nienhaus; Anja Schablon; Stephan Schlösser; Gerhard Schultze-Werninghaus; Gernot Rohde
Journal:  BMC Infect Dis       Date:  2010-07-23       Impact factor: 3.090

7.  Prevalence of latent tuberculosis infection among health care workers in a hospital for pulmonary diseases.

Authors:  Anja Schablon; Gudrun Beckmann; Melanie Harling; Roland Diel; Albert Nienhaus
Journal:  J Occup Med Toxicol       Date:  2009-01-09       Impact factor: 2.646

8.  In-hospital contact investigation among health care workers after exposure to smear-negative tuberculosis.

Authors:  Felix C Ringshausen; Stephan Schlösser; Albert Nienhaus; Anja Schablon; Gerhard Schultze-Werninghaus; Gernot Rohde
Journal:  J Occup Med Toxicol       Date:  2009-06-08       Impact factor: 2.646

9.  Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers.

Authors:  Irma Casas; Irene Latorre; Maria Esteve; Juan Ruiz-Manzano; Dora Rodriguez; Cristina Prat; Ignasi García-Olivé; Alicia Lacoma; Vicente Ausina; Jose Domínguez
Journal:  PLoS One       Date:  2009-08-24       Impact factor: 3.240

10.  Evaluation of the tuberculin skin test and the interferon-gamma release assay for TB screening in French healthcare workers.

Authors:  Dominique Tripodi; Benedicte Brunet-Courtois; Virginie Nael; Marie Audrain; Edmond Chailleux; Patrick Germaud; Frederique Naudin; Jean-Yves Muller; Martine Bourrut-Lacouture; Marie-Henriette Durand-Perdriel; Claire Gordeeff; Guyonne Guillaumin; Marietherese Houdebine; Francois Raffi; David Boutoille; Charlotte Biron; Gilles Potel; Claude Roedlich; Christian Geraut; Anja Schablon; Albert Nienhaus
Journal:  J Occup Med Toxicol       Date:  2009-11-30       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.